Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea: Changes in Microfilaremia, Filarial Antigen, and Bm14 Antibody after Cessation

Laboratory tools to monitor infection burden are important to evaluate progress and determine endpoints in programs to eliminate lymphatic filariasis. We evaluated changes in Wuchereria bancrofti microfilaria, filarial antigen and Bm14 antibody in individuals who participated in a five-year mass dru...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tisch, Daniel J., Bockarie, Moses J., Dimber, Zachary, Kiniboro, Benson, Tarongka, Nandao, Hazlett, Fred E., Kastens, Will, Alpers, Michael P., Kazura, James W.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2590750/
https://ncbi.nlm.nih.gov/pubmed/18256431
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares